Startups

At-home blood testing platform for cancer patients.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 23,000 COMPANIES →

Summary

Seedtable Score

Score icon 64

Locations

Company Size

  • 11 - 51

Last Stage Round

Industry

Insights

Entia addresses key pain points in the healthcare system by offering convenient and safe at-home blood testing for cancer patients. Traditional methods require travel to clinics or hospitals, which can be inconvenient and risky, potentially delaying crucial diagnostics. Entia’s platform minimizes these risks, enhances patient comfort, and allows for timely health monitoring. This unique value proposition makes it an attractive partner for healthcare providers, driving demand in the B2B market. Supported by investors like Business Growth Fund and Parkwalk Advisors, Entia is well-equipped to scale operations and leverage its innovative approach in the health tech sector.

Total Funding
$17.6M

Investors

Full Company Profile